MDS Virtual Congress 2021 Archives - Page 61 of 132

How Covid-19 would affect parkinsonism patients’ mortality

M. Salari, M. Etemadifar, S. Tehrani Fateh, Z. Aminzade (Tehran, Islamic Republic of Iran)
HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family

A. Orlacchio, M. Stasi, A. Stigliano, A. Meyyazhagan, T. Kawarai (Rome, Italy)
Humor processing is affected by Parkinson’s disease and levodopa

M. Prenger, K. van Hedger, K. Seergobin, A. Owen, P. Macdonald (London, Canada)
Hydrotherapy improves knees muscle power and dual task skills in Parkinson’s disease

J. Siega, D. Iucksch, A. Silva, V. Israel (Curitiba, Brazil)
Hyperhidrosis in Parkinson’s disease: a 3-year prospective cohort study

JY. Lin, RW. Ou, QQ. Wei, CY. Li, HF. Shang (Chengdu, China)
Hyperintensity in Middle Cerebellar Peduncles, an infrequent and reversible finding in Marchiafava-Bignami Disease.

D. López Domínguez, M. Puig Casadevall, G. álvarez Bravo (Girona, Spain)
Hyperkinetic Movement Disorders after Thalamic Lesions

S. Torabi, Y. Kianirad (Chicago, USA)
HYPERSEXUAL DISORDER IN GBA-ASSOCIATED PARKINSON’S DISEASE: CASE REPORT

M. Montenegro, C. Malcher, V. Cardoso, A. Escudeiro, A. Silva, B. Santos-Lobato (Belém, Brazil)
Identification of a new Homozygous mutation P.R258Q In the gene SYNJ1 of an Algerian consanguine (inbred) Family suffering from early onset atypical Parkinsonism

M. Benmahdjoub, N. Nesrine, S. Bouchetara, A. Bessad, S. Lesage, A. Brice, M. Arezki, S. Kesraoui (Blida, Algeria)
Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials

G. Roussos, R. Bhatnagar, J. Burton, J. Cosman, A. Derungs, A. Dowling, K. Fisher, D. Hill, K. Praneeth Kilambi, L. Evers, N. Mehrotra, M. Minchik, M. Muller, T. Ruiz Herrero, S. Sardar, D. Stephenson (London, United Kingdom)